Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simethicone Dosages with Minimal Normal Saline Volume to Enhance Mucosal Visualization in Upper Endoscopy
TCTR20240515001Phase 2Completed
- Sponsor
- Gastroenterological Association of Thailand
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of simethicone in Upper gastrointestinal mucosal visual impairment due to foam and bubbles, sponsored by Gastroenterological Association of Thailand. Started Jun 2024; status: completed.
02
Drugs
simethicone
03
Conditions
Upper gastrointestinal mucosal visual impairment due to foam and bubbles
Beyond the preview
Go deeper on TCTR20240515001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240515001.